Analysts expect Verrica Pharmaceuticals Inc. to report revenue of 6.78 M for Q3 26, against a range of 6.48 M to 7.09 M. The most recent reported quarter, Q2 26, came in at 5.86 M, a 6.2% beat against the 5.52 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.78 M | 344,000.00 | 3.44 M | 12.70 M | 14.34 M | 5.09 M | 5.02 M | 5.86 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 6.06 M | 1.10 M | 2.61 M | 4.85 M | 10.98 M | 4.76 M | 4.88 M | 5.78 M | 7.09 M | 8.57 M | 7.55 M | 9.80 M | 10.34 M | 9.88 M | 10.96 M | 12.50 M | ||||||||||
| Low Estimate | 5.02 M | 919,060.07 | 2.22 M | 4.09 M | 9.82 M | 3.91 M | 4.42 M | 5.25 M | 6.48 M | 7.52 M | 6.85 M | 8.62 M | 9.28 M | 9.27 M | 9.11 M | 11.61 M | ||||||||||
| Consensus Estimate | 5.54 M | 1.01 M | 2.41 M | 4.47 M | 10.40 M | 4.33 M | 4.65 M | 5.52 M | 6.78 M | 8.04 M | 7.20 M | 9.21 M | 9.81 M | 9.58 M | 10.03 M | 12.05 M |
Analysts expect Verrica Pharmaceuticals Inc. to report earnings per share of -0.52 for Q3 26, against a range of -0.55 to -0.49. The most recent reported quarter, Q2 26, came in at -0.62, a 55.0% miss against the -0.40 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -4.90 | -2.40 | -1.00 | 0.02 | -0.03 | -0.57 | -0.45 | -0.62 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -3.68 | -2.29 | -1.09 | -0.65 | -0.06 | -0.74 | -0.32 | -0.38 | -0.49 | -0.47 | -0.52 | -0.39 | 0.08 | 0.31 | -0.53 | -0.67 | ||||||||||
| Low Estimate | -4.06 | -2.45 | -1.31 | -0.79 | -0.06 | -0.88 | -0.36 | -0.42 | -0.55 | -0.51 | -0.58 | -0.47 | 0.06 | 0.25 | -0.63 | -0.79 | ||||||||||
| Consensus Estimate | -3.87 | -2.37 | -1.20 | -0.72 | -0.06 | -0.81 | -0.34 | -0.40 | -0.52 | -0.49 | -0.55 | -0.43 | 0.07 | 0.28 | -0.58 | -0.73 |
Pull Wall Street consensus for Verrica Pharmaceuticals Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=VRCA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "VRCA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=VRCA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();